Remove FDA Remove Healthcare Remove Retail
article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

The online retailer spends about $20 billion a year on R&D, despite being renowned for both low prices and low profits. years to win FDA approval, at a median cost of $648 million. More excess profit comes from the next 100 or 200 brand-name drugs. It’s Amazon. They found that companies took an average of 7.3

Insurance 181
article thumbnail

Walmart follows CVS, Walgreens into clinical trial sector

pharmaphorum

Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinical trials category, with the launch of a new institute that pledges to increase and diversify community access to healthcare research. Photo by Marques Thomas on Unsplash.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In the case of Novartis’ antihypertensive drug Exforge (amlodipine and valsartan), retail pharmacies including CVS, Walgreens, and two other plaintiff groups accused Novartis and Endo International’s Par Pharmaceutical unit of forming an illegal “reverse payment” agreement to delay the launch of less expensive generic versions of the drug.

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. Citizen Petitions before the FDA. 5) monitoring access to biosimilars.

article thumbnail

The Future of RWE in Clinical Trial Design and Recruitment

Clarify Health

Life sciences and healthcare are becoming united. Clapsis spoke about the role CVS Health is playing in capturing and using RWD for clinical research: “What’s really exciting now is that we have the ability to generate patient reported outcomes (PROs) and other observational data as part of the normal course of healthcare.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

We promptly discussed this need with the FDA and the agency agreed to a proposed amendment of the protocol to accommodate, in a safe manner, the patient access to the EAP.”. Previously he was with Accenture where he led large teams in outsourcing projects across Europe and US for clients in the transportation and retail businesses.

article thumbnail

The Future of RWE in Clinical Trial Design and Recruitment

Clarify Health

Life sciences and healthcare are becoming united. Clapsis spoke about the role CVS Health is playing in capturing and using RWD for clinical research: “What’s really exciting now is that we have the ability to generate patient reported outcomes (PROs) and other observational data as part of the normal course of healthcare.